Health Care

SMS Pharmaceuticals Limited (SMSPHARMA) Q2 FY23 Earnings Concall Transcript

● Aug 18, 2022

SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Q2 FY23 Earnings Concall Aug. 18, 2022 Corporate Participants: P. Vamsi Krishna — Executed Director LakshminarayanaTammineedi...

Apollo Hospitals research report at a glimpse

● Aug 17, 2022

Stock Data: Ticker APOLLOHOSP Exchange BSE and NSE  Industry Healthcare Why is the stock price rising? Shares of Apollo Hospitals...

Apollo Hospitals Enterprise Limited Q1 FY23 Earnings Conference Call Insights

● Aug 16, 2022

Key highlights from Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q1 FY23 Earnings Concall Q&A Highlights: Nitin Gosar from Invesco asked about...

Divi’s Laboratories Ltd Q1 FY23 Earnings Conference Call Insights

● Aug 15, 2022

Key highlights from Divi’s Laboratories Ltd (DIVISLAB) Q1 FY23 Earnings Concall Q&A Highlights: Tushar Manudhane from Motilal Oswal asked about...

Apollo Hospitals Enterprise Limited Q1FY23; 35% fall in Profits

● Aug 12, 2022

Revenue for Q1 FY23 has increased by 1% YoY to ₹ 37,956 millions. Profits have fallen by 35% YoY to...

Aurobindo Pharma Limited Q1FY23; 32% fall in Profits

● Aug 12, 2022

Revenue for Q1 FY23 has increased by 9% YoY to ₹ 6,235.9 crores. Profits have fallen by 32% YoY to...

Divi’s Laboratories Ltd (DIVISLAB) Q1 FY23 Earnings Concall Transcript

● Aug 12, 2022

Divi’s Laboratories Ltd (NSE:DIVISLAB) Q1 FY23 Earnings Concall dated Aug. 12, 2022 Corporate Participants: Satish Choudhury — Company Secretary and...

Infographic: Divi’s Lab Q1 results out, Net profit rises 26%

● Aug 12, 2022

On Friday, Pharmaceuticals company Divis Laboratories reported a 26% rise in its consolidated net profit at ₹702 crore as compared...

Hikal Limited (HIKAL) Q2 FY23 Earnings Concall Transcript

● Aug 11, 2022

Hikal Limited (NSE:HIKAL) Q2 FY23 Earnings Concall dated Aug. 11, 2022 Corporate Participants: Sameer Hiremath — Managing Director Manoj Mehrotra —...

Zydus Lifesciences Ltd Q1FY23; Profit suffer with rise in expenses

● Aug 10, 2022

Revenue for Q1 FY23 has increased by 1.8% YoY to ₹40,727 millions. Profits decreased by 12% YoY to ₹5,183 millions...